SCHEDULE: Polar Capital Discloses Verastem Stake

Polar Capital Holdings Plc, Polar Capital LLP, and Polar Capital Funds PLC report a beneficial ownership of 4.80% in Verastem, Inc.

Summary

• Polar Capital Holdings Plc, along with its affiliates Polar Capital LLP and Polar Capital Funds PLC - Biotechnology Fund, has filed a Schedule 13G, indicating a beneficial ownership of 3,700,000 shares of Verastem, Inc. common stock.
• This holding represents 4.80% of the class of securities outstanding.
• The filing confirms sole voting and dispositive power over these shares.
• The information is based on 77,154,709 shares outstanding as of January 12, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an investment firm and does not contain operational or financial performance updates from the issuer.

Positives

• Polar Capital has acquired a significant stake, suggesting confidence in Verastem's future prospects.
• The filing indicates clear control over voting and disposal of the shares held.

Risks

• The filing does not detail specific risks associated with Verastem, Inc. itself, but any investment carries inherent market risks.
• Changes in beneficial ownership can sometimes signal shifts in market sentiment or strategic intentions, which could impact share price.

Future Outlook

The filing itself is a disclosure of current ownership and does not contain forward-looking statements or guidance from Verastem, Inc. The future outlook for Verastem, Inc. would be found in other SEC filings by the company.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates Polar Capital's strategic interest in Verastem, Inc., a company likely operating within the biotechnology or pharmaceutical sector, given the name of one of the reporting entities (Polar Capital Funds PLC - Biotechnology Fund).

Stakeholder Impact

• Shareholders: The filing may influence investor perception of Verastem, Inc. due to the significant stake taken by an institutional investor.
• Management of Verastem, Inc.: May need to engage with Polar Capital regarding their investment strategy.
• Competitors: The investment may signal confidence in the sector Verastem operates within.

Next Steps

• Polar Capital will continue to hold and potentially manage its stake in Verastem, Inc.
• Future amendments to this Schedule 13G will be filed if there are changes in beneficial ownership.

Key Dates

Keywords

Schedule 13G, Verastem, Inc., Polar Capital Holdings Plc, Polar Capital LLP, Polar Capital Funds PLC, Beneficial Ownership, Common Stock, SEC Filing, Investment Management